The mineralocorticoid receptor as a modulator of innate immunity and atherosclerosis-Reference-Cited by-同舟云学术

The mineralocorticoid receptor as a modulator of innate immunity and atherosclerosis

Published:2018-04-16 Issue:7 Volume:114 Page:944-953
ISSN:0008-6363
Container-title:Cardiovascular Research
language:en
Short-container-title:

Author:

van der Heijden Charlotte D C C¹,Deinum Jaap¹,Joosten Leo A B¹,Netea Mihai G¹²,Riksen Niels P¹

Affiliation:

1. Department of Internal Medicine, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands

2. Department for Genomics & Immunoregulation, Life and Medical Sciences Institute (LIMES), University of Bonn, Carl-Troll-Straβe 31, 53115 Bonn, Germany

Funder

Dutch Heart Foundation

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine,Physiology

Link

http://academic.oup.com/cardiovascres/article-pdf/114/7/944/24845718/cvy092.pdf

Reference86 articles.

1. The cardioprotective effects of mineralocorticoid receptor antagonists;van den Berg;Pharmacol Ther,2014

2. Pharmacological treatment of aldosterone excess;Deinum;Pharmacol Ther,2015

3. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis;Monticone;Lancet Diabetes Endocrinol,2018

4. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction;Pitt;N Engl J Med,2003

5. The effect of spironolactone on morbidity and mortality in patients with severe heart failure;Pitt;N Engl J Med,1999

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential role of finerenone in patients with type 1 diabetes and chronic kidney disease;Diabetes, Obesity and Metabolism;2024-07-18

2. Analysis of eplerenone in the FDA adverse event reporting system (FAERS) database: a focus on overall patient population and gender-specific subgroups;Frontiers in Pharmacology;2024-07-17

3. Trained immunity: A link between risk factors and cardiovascular disease;British Journal of Pharmacology;2024-06-02

4. Relationship between the neutrophil-lymphocyte ratio and atherosclerosis in patients with primary aldosteronism;2024-04-29

5. Adverse Effects of Aldosterone: Beyond Blood Pressure;Journal of the American Heart Association;2024-04-02